In 2016, Peter Kristensen and Gareth Llewellyn started work on a strategy for the Wheatsheaf Group’s involvement in the cattle industry.
Following extensive research, consultation across the industry and hours of whiteboard sessions, they reached a key insight: the rate of increase in the volume and density of biological data being created and stored was not being matched by a similar increase in the rate of actionable insight being extracted from the data. In other words, more data did not mean more benefit.
From this insight, Peter and Gareth drew a hypothesis: if a technology could extract actionable insights from large, disparate biological datasets, it would have the potential to produce real value throughout agriculture, and not just the cattle industry.
They also determined two truths:
- As agriculture was often the last place cutting-edge technology was commercialized, practitioners in the industry were not being exposed to novel breakthroughs.
- And when technologies were being brought to market, they were usually offered by companies without deep experience in agriculture. As a result, these companies often overlooked many valuable applications for their technology.
So, Peter and Gareth set themselves a challenge: to find a revolutionary technology and pair it with leaders in agricultural production, industrial science, research and innovation, and commercial execution.
The story now moves forward to 2018 when Wheatsheaf Group completed an investment in a human health company with a revolutionary combinatorial analytics platform. They were using it to stratify patient populations and generate insights into the complex biology of chronic diseases. The company is now PrecisionLife.
As part of this investment, Wheatsheaf Group secured the right to an exclusive license to use the technology platform in agriculture. This right was crystallized in 2019 when the Wheatsheaf Group and PrecisionLife founded Synomics.
In stealth, Synomics got started in 2020, immediately beginning to build its expert team, as well as translating and expanding the technology platform to bring real value to the world of agriculture.
In late 2020, Synomics took another major step by partnering with Vytelle, granting them a license to use the platform in the cattle sector. This partnership effectively combines Synomics’ industry-leading insights platform with the gold standard in cattle phenotypic data capture and reproductive technology.
PrecisionLife’s unique combinatorial analytics platform generates more insights into the complex biology of chronic diseases, driving the next wave of precision medicine applications and finding new treatment opportunities for patients’ unmet medical needs.
PrecisionLife partners with disease charities, clinical research groups, CROs, best-of-breed technology providers, and pharma, biotech and healthcare companies to improve our knowledge of chronic disease biology. The company operates an innovation engine that translates proprietary disease biology insights into new drug discovery programs, more successful and cost-effective clinical trials, and more personalized clinical decision support tools.
PrecisionLife is headquartered near Oxford in the UK. It also has operations in Aalborg and Copenhagen, Denmark, Warsaw, Poland, and Cambridge, MA, USA.
Interested in driving the next agriculture revolution?
Join us on our journey pioneering the application of deep combinatorial analysis to help solve some of the world’s biggest challenges.